Viewing Study NCT03491150


Ignite Creation Date: 2025-12-24 @ 4:48 PM
Ignite Modification Date: 2025-12-25 @ 2:33 PM
Study NCT ID: NCT03491150
Status: TERMINATED
Last Update Posted: 2020-07-13
First Post: 2018-03-15
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: An Open-Label Crenezumab Study in Participants With Alzheimer's Disease
Sponsor: Hoffmann-La Roche
Organization: